drugset / Trial / NCT04220606

1H Magnetic Resonance Spectroscopy in Migraine Patients

NCT04220606

Non-randomizedParallel-groupOpen-labelBasic science

Summary

To investigate the glutaminergic system in the onset of migraine-like attacks.

Timeline

Start
2015-04
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Background Nitroglycerin Unknown 0.5 ug/kg Intravenous

Indications